RNU7-73P

Across TCGA pan-cancer cohorts, RNU7-73P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU7-73P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-73P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-73P expression acts as an unfavorable survival marker.

KIRC, SARC, and GBM are the cancer types where RNU7-73P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
SARC	OS	Tertile	All	0.146	0.866	<.001	36	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	18	view →
CESC	OS	Tertile	All	0.099	0.585	.049	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
THCA	OS	Tertile	III,IV	0.741	0.977	.023	9	view →
OV	OS	Tertile	III,IV	0.718	0.840	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU7-73P–KIRC (DFS)

Open the KIRC breakdown →